Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal VasculopathyAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22016-05-0161PREAI
Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative studyBRITISH JOURNAL OF OPHTHALMOLOGYIF3.52016-03-0734PREAI
Retinal Pigment Epithelial Tear After Intravitreal Ranibizumab Treatment for Retinal Angiomatous ProliferationAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22015-11-0117PREAI
Choroidal Vascular Hyperpermeability and Punctate Hyperfluorescent Spot in Choroidal NeovascularizationINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72015-03-3122PREAI
Risk Factors for Geographic Atrophy After Intravitreal Ranibizumab Injections for Retinal Angiomatous ProliferationAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22015-02-0179PREAI
Author Response: Pachychoroid Pigment Epitheliopathy May Masquerade as Acute Retinal Pigment EpitheliitisINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72014-08-220PREAI
Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedemaACTA OPHTHALMOLOGICAIF2.82014-07-1013PREAI
Acute Retinal Pigment Epitheliitis: Spectral-Domain Optical Coherence Tomography Findings in 18 CasesINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72014-05-2928PREAI
Small retinal haemorrhages accompanied by macular soft drusen: prevalence, and funduscopic and angiographic characteristicsBRITISH JOURNAL OF OPHTHALMOLOGYIF3.52014-03-2112PREAI
Effects of Choroidal Vascular Hyperpermeability on Anti-Vascular Endothelial Growth Factor Treatment for Polypoidal Choroidal VasculopathyAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22013-12-0165PREAI
Anti-Vascular Endothelial Growth Factor Monotherapy in the Treatment of Submacular Hemorrhage Secondary to Polypoidal Choroidal VasculopathyAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22013-09-0129PREAI